Is Medlab Clinical Ltd the best small cap healthcare buy on the ASX?

brokers are circling biological research company Medlab Clinical Ltd (ASX: MDC) as a potential buy

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stocks in the healthcare sector are getting a lot of airplay at the moment, with the likes of Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) experiencing sharp falls in its share price off the back of rising health premiums out of NIB Holdings Limited (ASX: NHF) and Medibank Private Ltd (ASX: MPL).

But at the small cap end of the scale brokers are circling biological research company Medlab Clinical Ltd (ASX: MDC) as a potential buy in, albeit, it is only one to consider for investors who don't mind speculative stocks in their portfolio.

Analysts at Asia Pacific Prudential Securities (APP) have placed a buy rating on Medlab with a $1.20 target price – Medlab shares were down 0.7% to 66c per share at the time of writing.

It is forecast by APP that Medlab is about to enter a period of strong earnings growth off the back of its medicinal marijuana products with NanaBis.

Medlab completed a $24 million capital raising in January this year, but will likely need to raise more capital soon for the rollout of its new products.

It's a speculative pick for sure, and investors would have to do their own research before they make the call on Medlab, but the company has been granted licenses to supply Schedule 8 drugs, which will include NanaBis under the governments Special Access Scheme (SAS).

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »